Black checkmark with a sparkle and a curved line underneath on a white background.
Company

AMERICAN SHARED HOSPITAL SERVICES

Ticker
AMS
Sector
Industry
Report date
November 14, 2026
Valye AI Score

92

Very high visibility
Recent developments
Recent developments summary

Recent developments highlight revenue growth and operational updates from earnings calls and news reports through 2026.

Recent developments:
  • American Shared Hospital Services reported third quarter 2026 revenue increased 6% to $7.6 million [N1].
  • The company held a Q3 2026 earnings call providing operational and financial details [N2].
  • Q2 2026 earnings call transcript was published detailing company performance [N3].
  • The company reported strong revenue growth in early 2026 [N4].
  • In Q1 2025, the company reported 17% year-over-year revenue growth and discussed expansion plans [N6][N5].
Overview

American Shared Hospital Services is a healthcare services company specializing in leasing advanced medical equipment such as Gamma Knife and Proton Beam Radiation Therapy units, alongside providing direct patient services. The company maintains multiple lease agreements with healthcare systems across the United States and internationally. Its business model centers on equipment leasing combined with patient service revenues. The company is publicly traded on the NYSE American exchange under the ticker AMS and is incorporated in California. Recent financial disclosures and earnings calls provide transparency into its operations and financial performance.

Executive summary

Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. American Shared Hospital Services reported third quarter 2026 revenue of $7.6 million, a 6% increase, with a net loss of $620,000 and EPS of -$0.09 per share as of September 30, 2026. The company’s liquidity ratios indicate current assets of $19.06 million against current liabilities of $23.63 million, resulting in a current ratio of 0.81 and a cash ratio of 0.31. The company operates medical equipment leasing and direct patient services, including Gamma Knife and Proton Beam Radiation Therapy equipment, with multiple lease agreements and recent upgrades. Recent earnings call transcripts provide detailed operational insights [S2][N1][N2].

Scenarios for AMS

Bull case model:

The company has demonstrated consistent revenue growth, including a 6% increase in third quarter 2026 revenue and prior periods of double-digit year-over-year growth. Its portfolio of leased advanced medical equipment and direct patient services provides diversified revenue streams. The presence of multiple lease amendments and upgrades indicates ongoing investment in maintaining and expanding its asset base. The company’s liquidity position, while below 1 in current ratio, is supported by cash and equivalents of $7.23 million as of September 30, 2026, enabling operational continuity.

Bear case model:

The company reported a net loss of $620,000 for the quarter ended September 30, 2026, with negative earnings per share. Its current ratio of 0.81 and cash ratio of 0.31 indicate liquidity constraints relative to current liabilities of $23.63 million. The capital-intensive nature of its business and reliance on lease agreements may expose it to risks if counterparties reduce usage or terminate contracts. Additionally, the company’s relatively small scale and limited public disclosure on broader market positioning may pose challenges in competitive and financial resilience.

Moat:

The company’s moat derives from its specialized leasing agreements for high-cost, advanced medical equipment such as Gamma Knife and Proton Beam Radiation Therapy units, which require significant capital investment and regulatory compliance. Long-term lease contracts with established healthcare providers create recurring revenue streams and barriers to entry for competitors. Additionally, the company’s operational expertise in managing and upgrading these specialized assets supports its competitive position.

Risks overview
Risks summary
Liquidity constraints combined with ongoing net losses represent the primary risks to the company’s operational and financial stability.
Risks details:

• Liquidity Risk: The company’s current ratio of 0.81 and cash ratio of 0.31 as of September 30, 2026, indicate potential liquidity constraints to meet short-term obligations.
• Operational Risk: Dependence on lease agreements with healthcare providers for specialized equipment exposes the company to counterparty risk and utilization fluctuations.
• Financial Performance Risk: The company reported a net loss and negative EPS in the latest quarter, reflecting challenges in profitability.
• Market and Competitive Risk: Limited disclosure on industry positioning and competition may affect the company’s ability to sustain growth and margins.

FINAL FORECAST FOR AMS

Final take one line
American Shared Hospital Services exhibits very high visibility with detailed financial disclosures and consistent revenue growth amid liquidity challenges.
Final take 12 to 24 month view

Business trends: The company shows consistent revenue growth driven by medical equipment leasing and patient services, supported by multiple lease agreements and upgrades.
Execution milestones: Recent earnings calls and amendments to lease agreements demonstrate ongoing operational management and asset maintenance.
Key risks: Liquidity constraints, net losses, and dependence on lease counterparties pose challenges to financial and operational stability.

Valye AI Visibility Research Score

Very high visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

92
LLM visibility overview
LLM Visibility known facts
  • American Shared Hospital Services operates in the healthcare sector providing medical equipment leasing and direct patient services, including Gamma Knife and Proton Beam Radiation Therapy equipment and services.
  • The company reported third quarter 2026 revenue of $7.6 million, representing a 6% increase compared to prior periods.
  • As of September 30, 2026, the company had cash and cash equivalents of $7.23 million and total current assets of $19.06 million.
  • Current liabilities as of September 30, 2026, were $23.63 million, resulting in a current ratio of 0.81 and a cash ratio of 0.31, indicating liquidity below 1.
  • The company reported a net loss of $620,000 for the quarter ended September 30, 2026, with basic and diluted EPS of -$0.09 per share.
  • The company has multiple lease agreements for Gamma Knife units and Proton Beam Radiation Therapy equipment with various healthcare systems, including recent amendments and upgrades.
  • The company has reported year-over-year revenue growth in prior quarters, including 17% growth in Q1 2025 and strong revenue growth reported in early 2026.
  • The company had 6,675,000 shares outstanding as of November 11, 2026.
  • The company is incorporated in California and trades on the NYSE American exchange under the ticker AMS.
  • The company has adopted a Code of Ethics and an Insider Trading Policy as disclosed in its 2026 Proxy Statement.
  • Recent earnings call transcripts for Q2 and Q3 2026 provide detailed operational and financial discussions.
  • The company’s total assets were $52.87 million as of September 30, 2026, with property and equipment net of $27.33 million.
  • The company’s goodwill and intangible assets were $1.265 million and $78,000 respectively as of September 30, 2026.
  • The company’s liabilities include related party liabilities and asset retirement obligations.
  • The company’s financial figures are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.
Sources
Sources - Context summary

Generated 2026-11-14

Sources - Earning calls
  • N2
  • N3
  • N5
Sources - Other context
Sources - SEC Filings
  • S1 | 2026-03-31 | 10-K
  • S2 | 2026-11-13 | 10-Q
Sources - News headlines
  • N1 | 2026-11-13 | www.nasdaq.com | American Shared Hospital Services Reports Third Quarter Revenue Increased 6% to $7.6 Million | https://www.nasdaq.com/articles/american-shared-hospital-services-reports-third-quarter-revenue-increased-6-76-million
  • N2 | 2026-11-13 | www.nasdaq.com | American Shared Hospital (AMS) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/american-shared-hospital-ams-q3-2026-earnings-call-transcript
  • N3 | 2026-08-20 | www.nasdaq.com | AMS (AMS) Q2 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/ams-ams-q2-2026-earnings-call-transcript
  • N4 | 2026-03-31 | www.nasdaq.com | American Shared Hospital Services Reports Strong Revenue Growth | https://www.nasdaq.com/articles/american-shared-hospital-services-reports-strong-revenue-growth
  • N5 | 2025-05-15 | www.nasdaq.com | American Shared Hospital Services Q1 25 Earnings Conference Call At 12:00 PM ET | https://www.nasdaq.com/articles/american-shared-hospital-services-q1-25-earnings-conference-call-12-00-pm-et
  • N6 | 2025-05-15 | www.nasdaq.com | American Shared Hospital Services Reports 17% Year Over Year Revenue Growth for Q1 2025 and Expansion Plans | https://www.nasdaq.com/articles/american-shared-hospital-services-reports-17-year-over-year-revenue-growth-q1-2025-and
  • N7 | 2025-04-04 | www.nasdaq.com | $AMS Earnings Results: $AMS Reports Quarterly Earnings | https://www.nasdaq.com/articles/ams-earnings-results-ams-reports-quarterly-earnings
  • N8 | 2025-03-25 | www.nasdaq.com | $AMS Earnings Preview: Recent $AMS Insider Trading, Hedge Fund Activity, and More | https://www.nasdaq.com/articles/ams-earnings-preview-recent-ams-insider-trading-hedge-fund-activity-and-more
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine